BY THE NUMBERS.
WHERE IT LANDED.
HOW FULL THE BUS GOT.
TICKET CLASSES.
HOW THE ISSUE IS BUILT.
The two legs send the money to different places: a fresh issue raises new capital for the company, while an offer for sale is existing shares being sold by existing shareholders, whose proceeds go to those sellers and not to the company.
ON THE DASHBOARD.
THE RUNNING RECORD.
WHO ELSE RUNS THIS LINE.
Notes: Basic and Diluted EPS refers to the Basic and Diluted EPS sourced from the financial statements of the companies respectively for the Fiscal ended March 31, 2026 Price/earnings ratio for the peers has been computed based on the closing market price of equity shares on NSE as on July 21, 2026 divided by the diluted earnings per share for financial year ended March 31, 2026 Net Asset Value per share is calculated as net worth at the end of the year divided by number of equity shares outstanding at the end of the year. Number of equity shares outstanding at the end of the year is an aggregate of outstanding number of equity shares considering dilutive number of shares. Return on Net Worth is calculated as Profit/(loss) for the year attributable to owners of the Company divided by Net Worth as of at the end of the respective year. Net Worth has been defined as the aggregate value of the paid-up share capital and all reserves created out of the profits and securities premium account and debit or credit balance of restated consolidated statement of profit and loss, after deducting the aggregate value of the accumulated losses, deferred expenditure and miscellaneous expenditure not written off, as per the restated consolidated statement of assets and liabilities, but does not include reserves created out of revaluation of assets, write-back of depreciation and amalgamation. Further, Net Worth is calculated as the sum of equity share capital, other equity, foreign currency translation reserve, and adjustments for re-measurement of the defined benefit plan.
WHAT THE MONEY IS FOR.
WHO GETS WHICH SEATS.
Manipal Health Enterprises Limited is one of India's leading healthcare organizations, providing comprehensive medical services through an extensive network of hospitals, clinics, and diagnostic facilities. As a part of the Manipal Group, established by Dr. T. M. A. Pai, the company has built a strong presence in the healthcare sector through its focus on clinical excellence and patient care. The company delivers a broad spectrum of healthcare services across multiple specialties, including advanced tertiary and quaternary care. Its key service areas encompass oncology, cardiology, neurology, orthopaedics, organ transplantation, critical care, and preventive healthcare. The hospitals are supported by modern medical infrastructure, advanced diagnostic technologies, and highly qualified healthcare professionals. Manipal Health pursues a patient-focused approach by continuously enhancing its healthcare capabilities, expanding its geographic reach, and investing in medical technology and digital healthcare solutions. The company has strengthened its market position through strategic acquisitions, partnerships, and capacity expansion initiatives. As of September 30, 2025, Manipal Health operated a network of 38 hospitals, which increased to 48 hospitals on a pro forma basis. The company had a licensed bed capacity of 10,761 beds, rising to 12,367 beds on a pro forma basis. In addition, it operated 17 clinics across its healthcare network. Key Competitive Advantages One of India's largest multispecialty hospital networks by bed capacity, with a strong presence across key regions of the country. Unique leadership position among private hospital chains with a significant presence in major metropolitan markets, including Bengaluru, Kolkata, and Pune, complemented by a balanced footprint in non-metro locations. Well-established healthcare brand trusted by patients, physicians, and medical professionals. State-of-the-art medical infrastructure and advanced equipment supported by a strong commitment to clinical quality and patient outcomes. Demonstrated track record of sustained growth, operational efficiency, and profitability within the healthcare sector.
ON THE ROSTER.
COMMON QUESTIONS.
What is the Manipal Health Enterprises IPO price band?+
The indicative price band is ₹590 per share. The binding terms are the ones in the Red Herring Prospectus (RHP).
What is the lot size of the Manipal Health Enterprises IPO?+
One lot is 25 shares. At the upper band of ₹590, one lot works out to ₹14,750.
How many lots can a retail investor apply for in the Manipal Health Enterprises IPO?+
A retail application runs from 1 lot (25 shares, ₹14,750) up to 13 lots (325 shares, ₹1,91,750) — the most that fits under SEBI's ₹2 lakh retail ceiling.
What is the minimum HNI application in the Manipal Health Enterprises IPO?+
A small-HNI (sHNI) application starts at 14 lots — 350 shares, ₹2,06,500. A big-HNI (bHNI) application starts at 68 lots — 1,700 shares, ₹10,03,000, above the ₹10 lakh boundary.
When does the Manipal Health Enterprises IPO open and close?+
The issue opened on 29 Jul 2026 and closed on 31 Jul 2026. Dates can move — the registrar and the exchange notices are the record.
When is the Manipal Health Enterprises IPO allotment?+
Allotment is scheduled for 03 Aug 2026. The basis of allotment is published by the registrar to the issue. BuyUnlistedShares does not accept, process or track IPO applications.
When did Manipal Health Enterprises list?+
Listing took place on 05 Aug 2026 on NSE, BSE.
Where will Manipal Health Enterprises be listed?+
Manipal Health Enterprises is listed on NSE, BSE. It is a mainboard issue.
How large is the Manipal Health Enterprises IPO?+
The issue size is ₹9275.22 Cr — a fresh issue of ₹8,000 cr and an offer for sale of ₹1,275.22 cr. Figures are indicative and subject to the RHP.
What is the difference between the fresh issue and the offer for sale in the Manipal Health Enterprises IPO?+
Money raised through the fresh issue goes to the company, which spends it on the purposes set out in the offer document. Money raised through the offer for sale goes to the shareholders who are selling, not to the company. That is a fact about how the issue is structured, not a view on it.
How was the Manipal Health Enterprises IPO subscribed?+
The issue was subscribed 5.12× overall. By category: qib 8.54×, nii 1.06×, small hni 0.94×, big hni 1.13×, retail 0.98×. Subscription figures are as reported by the exchanges.
At what price did Manipal Health Enterprises list?+
Manipal Health Enterprises listed at ₹652, +10.51% against the issue price.
Who is the registrar for the Manipal Health Enterprises IPO?+
The registrar to the issue is Kfin Technologies Ltd. (040-79615565), manipal.ipo@kfintech.com.
Where can I check the Manipal Health Enterprises IPO allotment status?+
Allotment status is published by the registrar on its own official portal: https://ipostatus.kfintech.com/. Use the registrar's site directly — BuyUnlistedShares does not ask for PAN, application numbers or any other applicant detail.